Host Mechanisms Involved in Achieving SVR Using Grazoprevir and Elbasvir in Treatment of Chronic Hepatitis C in Patients With CKD Before and After Renal Transplantation
Phase of Trial: Phase IV
Latest Information Update: 19 May 2017
At a glance
- Drugs Elbasvir/grazoprevir (Primary)
- Indications Hepatitis C
- Focus Pharmacodynamics; Pharmacogenomic; Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 13 May 2017 Status changed from not yet recruiting to recruiting.
- 21 Nov 2016 Planned initiation date changed from 1 Sep 2016 to 1 Dec 2016.